← Back to Search

Legal Aid and Training for HIV Care

N/A
Recruiting
Research Sponsored by University of Central Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve HIV care for people who have been in prison by combining legal help with medical care. The program trains healthcare and legal staff to work together and provides integrated services to remove barriers to treatment.

Who is the study for?
This trial is for individuals who were previously incarcerated and are living with HIV/AIDS. It aims to explore how legal aid can improve their health outcomes. Participants should be interested in receiving legal assistance and willing to engage with healthcare providers trained in medical-legal partnerships.
What is being tested?
The study tests the effect of providing legal aid on HIV care for those formerly incarcerated, alongside a training program for healthcare providers. The goal is to see if these interventions help patients stay on track with their HIV treatment and improve communication among caregivers.
What are the potential side effects?
Since this trial involves non-medical interventions like legal aid and provider training, traditional physical side effects are not applicable. However, participants may experience stress or anxiety related to discussing legal issues or personal health information.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
HIV viral load using polymerase chain reaction (PCR)
Secondary study objectives
Quality of Life checklist

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: CTI-MLP assessmentExperimental Treatment1 Intervention
To assess the feasibility and acceptability of a comprehensive critical-time intervention medical legal partnership (CTI-MLP) approach to improve HIV care continuum outcomes among formerly incarcerated individuals and determine the most efficient mechanisms for CTI-MLP delivery
Group II: CTI-MLP approachExperimental Treatment1 Intervention
To finalize protocols and a medical-legal partnership training manual for health and social service providers at Hope and Help Inc.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for HIV/AIDS involve antiretroviral therapy (ART), which includes several classes of drugs: nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs) inhibit the reverse transcriptase enzyme, preventing the conversion of viral RNA into DNA; protease inhibitors (PIs) block the protease enzyme, preventing the maturation of viral proteins; integrase strand transfer inhibitors (INSTIs) inhibit the integrase enzyme, preventing the integration of viral DNA into the host genome; and entry inhibitors prevent the virus from entering host cells. These treatments are crucial for reducing viral load, preventing disease progression, and improving the quality of life for HIV/AIDS patients, which is particularly important in comprehensive care approaches like those studied in the Legal Aid trial.

Find a Location

Who is running the clinical trial?

Hope and Help Center of Central Florida IncorporatedUNKNOWN
University of MiamiOTHER
955 Previous Clinical Trials
428,748 Total Patients Enrolled
University of Central FloridaLead Sponsor
93 Previous Clinical Trials
1,120,126 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,936 Previous Clinical Trials
2,751,541 Total Patients Enrolled
~39 spots leftby Oct 2025